Biomedical Engineering Reference
In-Depth Information
320. Roller A, Bahr OR, Streffer J, Winter S, Heneka M, Deininger M, Meyermann R, Nau-
mann U, Gulbins E, Weller M. 1999. Selective potentiation of drug cytotoxicity by NSAID
in human glioma cells: the role of COX-1 and MRP. Biochem Biophys Res Commun 259:
600-605.
321. Gekeler V, Ise W, Sanders KH, Ulrich WR, Beck J. 1995. The leukotriene LTD4 receptor
antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem
Biophys Res Commun 208: 345-352.
322. Nakano R, Oka M, Nakamura T, Fukuda M, Kawabata S, Terashi K, Tsukamoto
K, Noguchi Y, Soda H, Kohno S. 1998. A leukotriene receptor antagonist, ONO-
1078, modulates drug sensitivity and leukotriene C4 efflux in lung cancer cells ex-
pressing multidrug resistance protein. Biochem Biophys Res Commun 251: 307-
312.
323. Payen L, Delugin L, Courtois A, Trinquart Y, Guillouzo A, Fardel O. 2001. The sulpho-
nylurea glibenclamide inhibits multidrug resistance protein (MRP1) activity in human
lung cancer cells. Br J Pharmacol 132 (Feb): 778-784.
324. Burg D, Wielinga P, Zelcer N, Saeki T, Mulder GJ, Borst P. 2002. Inhibition of the
multidrug resistance protein 1 (MRP1) by peptidomimetic glutathione-conjugate analogs.
Mol Pharmacol 62: 1160-1166.
325. Norman BH, Dantzig AH, Kroin JS, Law KL, Tabas LB, Shepard RL, Palkowitz AD,
Hauser KL, Winter MA, Sluka JP, Starling JJ. 1999. Reversal of resistance in multidrug
resistance protein (MRP1)-overexpressing cells by LY329146. Bioorg Med Chem Lett
9: 3381-3386.
326. Norman BH, Gruber JM, Hollinshead SP, Wilson JW, Starling JJ, Law KL, Self TD,
Tabas LB, Williams DC, Paul DC, Wagner MM, Dantzig AH. 2002. Tricyclic isoxazoles
are novel inhibitors of the multidrug resistance protein (MRP1). Bioorg Med Chem Lett
12: 883-886.
327. Norman BH, Lander PA, Gruber JM, Kroin JS, Cohen JD, Jungheim LN, Starling JJ, Law
KL, Self TD, Tabas LB, et al. 2005. Cyclohexyl-linked tricyclic isoxazoles are potent and
selective modulators of the multidrug resistance protein (MRP1). Bioorg Med Chem Lett
15: 5526-5530.
328. Loe DW, Deeley RG, Cole SPC. 2000. Verapamil stimulates glutathione transport by
the 190-kDa multidrug resistance protein 1 (MRP1). J Pharmacol Exp Ther 296: 530-
538.
329. Aoki S, Chen ZS, Higasiyama K, Setiawan A, Akiyama S, Kobayashi M. 2001. Revers-
ing effect of agosterol A, a spongean sterol acetate, on multidrug resistance in human
carcinoma cells. Jpn J Cancer Res 92: 886-895. Abstract only.
330. Sumizawa T, Chen ZS, Chuman Y, Seto K, Furukawa T, Haraguchi M, Tani A, Shudo N,
Akiyama SI. 1997. Reversal of multidrug resistance-associated protein-mediated drug
resistance by the pyridine analog PAK-104P. Mol Pharmacol 51: 399-405.
331. Marbeuf-Gueye C, Salerno M, Quidu P, Garnier-Suillerot A. 2000. Inhibition of the P-
glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and
calceinacetoxymethyl ester by PAK-104P. Eur J Pharmacol 391: 207-216.
332. Bichat F, Solis-Recendez G, Poullain MG, Poupon MF, Khayat D, Bastian G. 1998.
S9788 modulation of P-glycoprotein- and multidrug-related protein-mediated multidrug
resistance by Servier 9788 in doxorubicin-resistant MCF7 cells. Biochem Pharmacol 56:
497-502.
Search WWH ::
Custom Search